Manufacture of pharmaceutical preparations
CURIDA HOLDING AS
Revenue 2024
NOK 13.8m
Operating profit
NOK −1.5m
Equity
NOK 196.1m
Incorporated
2015
Share capital
NOK 11.2m
Key figures · 2024
Current ratio
2.66
Equity ratio
80.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -11.0% | |
| Net margin (%%) | 99.2% | |
| Return on assets (%%) | -0.6% | |
| Likviditet | ||
| Current ratio | 2.66 | |
| Working capital | 80.9m | |
| Soliditet | ||
| Equity ratio (%%) | 80.1% | |
| Debt-to-equity ratio | 0.25 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.